BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

34 related articles for article (PubMed ID: 15699114)

  • 1. Penetratin tandemly linked to a CTL peptide induces anti-tumour T-cell responses via a cross-presentation pathway.
    Pouniotis DS; Apostolopoulos V; Pietersz GA
    Immunology; 2006 Mar; 117(3):329-39. PubMed ID: 16476052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of Phagocytic and Antigen Cross-Presenting Capacity in Aging Dendritic Cells Is Associated with Mitochondrial Dysfunction.
    Chougnet CA; Thacker RI; Shehata HM; Hennies CM; Lehn MA; Lages CS; Janssen EM
    J Immunol; 2015 Sep; 195(6):2624-32. PubMed ID: 26246142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spatial separation of the processing and MHC class I loading compartments for cross-presentation of the tumor-associated antigen HER2/
    Baleeiro RB; Rietscher R; Diedrich A; Czaplewska JA; Lehr CM; Scherließ R; Hanefeld A; Gottschaldt M; Walden P
    Oncoimmunology; 2015 Nov; 4(11):e1047585. PubMed ID: 26985398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple low-dose challenges in a rhesus macaque AIDS vaccine trial result in an evolving host response that affects protective outcome.
    Selinger C; Strbo N; Gonzalez L; Aicher L; Weiss JM; Law GL; Palermo RE; Vaccari M; Franchini G; Podack ER; Katze MG
    Clin Vaccine Immunol; 2014 Dec; 21(12):1650-60. PubMed ID: 25274805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD13 is dispensable for normal hematopoiesis and myeloid cell functions in the mouse.
    Winnicka B; O'Conor C; Schacke W; Vernier K; Grant CL; Fenteany FH; Pereira FE; Liang B; Kaur A; Zhao R; Montrose DC; Rosenberg DW; Aguila HL; Shapiro LH
    J Leukoc Biol; 2010 Aug; 88(2):347-59. PubMed ID: 20430777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MHC class I endosomal and lysosomal trafficking coincides with exogenous antigen loading in dendritic cells.
    Basha G; Lizée G; Reinicke AT; Seipp RP; Omilusik KD; Jefferies WA
    PLoS One; 2008 Sep; 3(9):e3247. PubMed ID: 18802471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant complexes of antigen with stress proteins are potent CD8 T-cell-stimulating immunogens.
    Wieland A; Denzel M; Schmidt E; Kochanek S; Kreppel F; Reimann J; Schirmbeck R
    J Mol Med (Berl); 2008 Sep; 86(9):1067-79. PubMed ID: 18551265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigen release kinetics in the phagosome are critical to cross-presentation efficiency.
    Howland SW; Wittrup KD
    J Immunol; 2008 Feb; 180(3):1576-83. PubMed ID: 18209053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular uptake followed by class I MHC presentation of some exogenous peptides contributes to T cell stimulatory capacity.
    Brophy SE; Jones LL; Holler PD; Kranz DM
    Mol Immunol; 2007 Mar; 44(9):2184-94. PubMed ID: 17169430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heat shock proteins in antigen trafficking--implications on antigen presentation to T cells.
    Udono H; Ichiyanagi T; Mizukami S; Imai T
    Int J Hyperthermia; 2009 Dec; 25(8):617-25. PubMed ID: 19551545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging roles for scavenger receptor SREC-I in immunity.
    Murshid A; Borges TJ; Calderwood SK
    Cytokine; 2015 Oct; 75(2):256-60. PubMed ID: 25767073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple intracellular routes in the cross-presentation of a soluble protein by murine dendritic cells.
    Palliser D; Guillen E; Ju M; Eisen HN
    J Immunol; 2005 Feb; 174(4):1879-87. PubMed ID: 15699114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of MHC class I presentation of exogenous antigen by dendritic cells is controlled by CD4+ T cells engaging class II molecules in cholesterol-rich domains.
    Machy P; Serre K; Baillet M; Leserman L
    J Immunol; 2002 Feb; 168(3):1172-80. PubMed ID: 11801652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The B subunit of Shiga toxin fused to a tumor antigen elicits CTL and targets dendritic cells to allow MHC class I-restricted presentation of peptides derived from exogenous antigens.
    Haicheur N; Bismuth E; Bosset S; Adotevi O; Warnier G; Lacabanne V; Regnault A; Desaymard C; Amigorena S; Ricciardi-Castagnoli P; Goud B; Fridman WH; Johannes L; Tartour E
    J Immunol; 2000 Sep; 165(6):3301-8. PubMed ID: 10975847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selection of an antibody library identifies a pathway to induce immunity by targeting CD36 on steady-state CD8 alpha+ dendritic cells.
    Tagliani E; Guermonprez P; Sepúlveda J; López-Bravo M; Ardavín C; Amigorena S; Benvenuti F; Burrone OR
    J Immunol; 2008 Mar; 180(5):3201-9. PubMed ID: 18292544
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.